Kiemeneij F - Search Results

1

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.

Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, et al. Serruys PW, et al. Among authors: kiemeneij f. N Engl J Med. 1994 Aug 25;331(8):489-95. doi: 10.1056/NEJM199408253310801. N Engl J Med. 1994. PMID: 8041413 Free article. Clinical Trial.

2

Clinical and angiographic outcome of elective stent implantation in small coronary vessels: an analysis of the BENESTENT trial.

Keane D, Azar AJ, de Jaegere P, Rutsch W, de Bruyne B, Legrand V, Kiemeneij F, de Feyter P, van de Heuvel P, Ozaki Y, Morel MA, Serruys PW. Keane D, et al. Among authors: kiemeneij f. Semin Interv Cardiol. 1996 Dec;1(4):255-62. Semin Interv Cardiol. 1996. PMID: 9552519 Clinical Trial.

3

Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II).

Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C, Sousa E, van der Giessen W, Colombo A, Seabra-Gomes R, Kiemeneij F, Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugmann S, Morel MA. Serruys PW, et al. Among authors: kiemeneij f. Lancet. 1998 Aug 29;352(9129):673-81. doi: 10.1016/s0140-6736(97)11128-x. Lancet. 1998. PMID: 9728982 Clinical Trial.

4

Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial.

Kiemeneij F, Serruys PW, Macaya C, Rutsch W, Heyndrickx G, Albertsson P, Fajadet J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, Disco CM, Morel MA. Kiemeneij F, et al. J Am Coll Cardiol. 2001 May;37(6):1598-603. doi: 10.1016/s0735-1097(01)01207-4. J Am Coll Cardiol. 2001. PMID: 11345371 Free article. Clinical Trial.

5

Safe and effective direct implantation of a new stent through 5 F. guiding catheters with delivery from the radial artery: initial results of a prospective registry.

IJsselmuiden AJ, Cotton JM, Slagboom T, van der Wieken R, Kiemeneij F, Serruys PW, Laarman G. IJsselmuiden AJ, et al. Among authors: kiemeneij f. Int J Cardiovasc Intervent. 2003;5(2):72-6. doi: 10.1080/14628840310003253. Int J Cardiovasc Intervent. 2003. PMID: 12745862

6

First international new intravascular rigid-flex endovascular stent study (FINESS): clinical and angiographic results after elective and urgent stent implantation. The FINESS Trial Investigators.

Almagor Y, Feld S, Kiemeneij F, Serruys PW, Morice MC, Colombo A, Macaya C, Guermonprez JL, Marco J, Erbel R, Penn IM, Bonan R, Leon MB. Almagor Y, et al. Among authors: kiemeneij f. J Am Coll Cardiol. 1997 Oct;30(4):847-54. doi: 10.1016/s0735-1097(97)00269-6. J Am Coll Cardiol. 1997. PMID: 9316508 Free article. Clinical Trial.

7

Direct coronary stent implantation does not reduce the incidence of in-stent restenosis or major adverse cardiac events: six month results of a randomized trial.

IJsselmuiden AJ, Serruys PW, Scholte A, Kiemeneij F, Slagboom T, vd Wieken LR, Tangelder GJ, Laarman GJ. IJsselmuiden AJ, et al. Among authors: kiemeneij f. Eur Heart J. 2003 Mar;24(5):421-9. doi: 10.1016/s0195-668x(02)00701-7. Eur Heart J. 2003. PMID: 12633544 Clinical Trial.

8

Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison.

Ijsselmuiden AJ, Ezechiels J, Westendorp IC, Tijssen JG, Kiemeneij F, Slagboom T, van der Wieken R, Tangelder G, Serruys PW, Laarman G. Ijsselmuiden AJ, et al. Among authors: kiemeneij f. Am Heart J. 2004 Sep;148(3):467-74. doi: 10.1016/j.ahj.2004.03.026. Am Heart J. 2004. PMID: 15389234 Clinical Trial.

9

Direct coronary stenting compared with stenting after predilatation is feasible, safe, and more cost-effective in selected patients: evidence to date indicating similar late outcomes.

Ijsselmuiden AJ, Tangelder GJ, Cotton JM, Vaijifdar B, Kiemeneij F, Slagboom T, v d Wieken R, Serruys PW, Laarman GJ. Ijsselmuiden AJ, et al. Among authors: kiemeneij f. Int J Cardiovasc Intervent. 2003;5(3):143-50. doi: 10.1080/14628840310017807. Int J Cardiovasc Intervent. 2003. PMID: 12959731 Review.

10

Feasibility, safety, and preliminary efficacy of a novel ePTFE-covered self-expanding stent in saphenous vein graft lesions: the Symbiot II trial.

Laarman GJ, Kiemeneij F, Mueller R, Guagliumi G, Cobaugh M, Serruys PW; Symbiot II Trial Investigators. Laarman GJ, et al. Among authors: kiemeneij f. Catheter Cardiovasc Interv. 2005 Mar;64(3):361-8. doi: 10.1002/ccd.20282. Catheter Cardiovasc Interv. 2005. PMID: 15736242 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters